BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 20868687)

  • 1. Lycopene possess an antimalarial effect on chloroquine-resistant malaria and its hematological aberrations in murine model.
    Idih FM; Atanu FO; Ndu CK; Michael RE; Kadiri B; Jimoh LO; Usman BO; Ogugua VN
    Parasitol Int; 2024 Aug; 101():102873. PubMed ID: 38428566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug selection pressure and fitness cost for artemether-resistant Plasmodium berghei ANKA parasites in vivo.
    Waithera MW; Sifuna MW; Kimani SK; Takei M
    Int J Antimicrob Agents; 2023 Dec; 62(6):107012. PubMed ID: 37865152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cryptic cycle in haematopoietic niches promotes initiation of malaria transmission and evasion of chemotherapy.
    Lee RS; Waters AP; Brewer JM
    Nat Commun; 2018 Apr; 9(1):1689. PubMed ID: 29703959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fitness of drug-resistant malaria parasites in a rodent model: multiplicity of infection.
    Huijben S; Sim DG; Nelson WA; Read AF
    J Evol Biol; 2011 Nov; 24(11):2410-22. PubMed ID: 21883612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-resistant malaria - an insight.
    Hyde JE
    FEBS J; 2007 Sep; 274(18):4688-98. PubMed ID: 17824955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Combination of Azithromycin and Naphthoquine in Animal Malaria Models.
    Bei ZC; Li GF; Zhao JH; Zhang M; Ji XG; Wang JY
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32839220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gender-related variability in the pharmacokinetics and antiplasmodial activity of naphthoquine in rodents.
    Xie Y; Liu H; Sun Y; Xing J
    Malar J; 2020 Feb; 19(1):71. PubMed ID: 32054478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naphthoquine: An Emerging Candidate for Artemisinin Combination Therapy.
    Moore BR; Laman M; Salman S; Batty KT; Page-Sharp M; Hombhanje F; Manning L; Davis TM
    Drugs; 2016 May; 76(7):789-804. PubMed ID: 27075024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent Ex Vivo Activity of Naphthoquine and Methylene Blue against Drug-Resistant Clinical Isolates of Plasmodium falciparum and Plasmodium vivax.
    Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Trianty L; Kenangalem E; Noviyanti R; Campo B; Poespoprodjo JR; Möhrle JJ; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6117-24. PubMed ID: 26195523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the in vivo tolerance and in vitro reduced susceptibility to the antimalarial lumefantrine.
    Nzila A; Okombo J; Ohuma E; Al-Thukair A
    J Antimicrob Chemother; 2012 Oct; 67(10):2309-15. PubMed ID: 22761327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisinin-naphthoquine for treating uncomplicated Plasmodium falciparum malaria.
    Isba R; Zani B; Gathu M; Sinclair D
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD011547. PubMed ID: 25702785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium berghei K173: selection of resistance to naphthoquine in a mouse model.
    Wang H; Bei ZC; Wang JY; Cao WC
    Exp Parasitol; 2011 Feb; 127(2):436-9. PubMed ID: 20868687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium berghei ANKA: selection of resistance to piperaquine and lumefantrine in a mouse model.
    Kiboi DM; Irungu BN; Langat B; Wittlin S; Brun R; Chollet J; Abiodun O; Nganga JK; Nyambati VC; Rukunga GM; Bell A; Nzila A
    Exp Parasitol; 2009 Jul; 122(3):196-202. PubMed ID: 19318094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vivo antimalarial activity of novel naphthoquine derivatives with linear/cyclic structured pendants.
    Tang L; Bei Z; Song Y; Xu L; Wang H; Zhang D; Dou Y; Lv K; Wang H
    Future Med Chem; 2017 Jul; 9(11):1117-1127. PubMed ID: 28513196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fitness cost of resistance for lumefantrine and piperaquine-resistant Plasmodium berghei in a mouse model.
    Gimode WR; Kiboi DM; Kimani FT; Wamakima HN; Burugu MW; Muregi FW
    Malar J; 2015 Jan; 14():38. PubMed ID: 25627576
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.